Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 40 for Clostridium difficile infection

Edit search filters
  1. Treatment of Recurrent Clostridium Difficile Infection with RBX7455

    Rochester, MN

  2. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

    Scottsdale/Phoenix, AZ

  3. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3)

    Scottsdale/Phoenix, AZ

  4. A Study of the Effectiveness of the Electronic Nose with C. difficile Infected Stool

  5. A Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  6. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

    Rochester, MN

  7. SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)

    Rochester, MN

  8. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

    Jacksonville, FL

  9. Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)

    Rochester, MN

  10. A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea

    Rochester, MN

.

Mayo Clinic Footer